NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE:UNH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired UnitedHealth securities between September 22, 2021 and April 16, 2025, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Compass Diversified Holdings ("Compass" or "the Company") (NYSE:CODI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Compass securities between May 1, 2024 and May 7, 2025, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Open Lending Corporation ("Open Lending" or "the Company") (NASDAQ:LPRO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Open Lending securities between February 24, 2022 and March 31, 2025, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Civitas Resources, Inc. ("Civitas" or "the Company") (NYSE:CIVI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rock Holdings, Inc. ("RHI" or "the Company") (NYSE:RKT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Rocket Companies, Inc. ("Rocket") Class A common stock between February 25, 2021 and May 5, 2021, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bitfarms Ltd. ("Bitfarms" or "the Company") (NASDAQ:BITF) and certain of its officers.

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Digimarc Corporation ("Digimarc" or "the Company") (NASDAQ:DMRC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Digimarc securities between May 3, 2024 and February 26, 2025, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ:IOVA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Iovance securities between May 9, 2024 and May 8, 2025, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Treace Medical securities between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against NAPCO Security Technologies, Inc. ("NAPCO" or "the Company") (NASDAQ:NSSC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired NAPCO securities between February 5, 2024 and February 3, 2025, both dates inclusive (the "Class Period").

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that it has been selected by Airbus UpNext, a wholly-owned Airbus subsidiary created to explore innovative technologies, to supply its cutting-edge 4D LiDAR technology for the Optimate smart automation demonstrator. Aeva's unique 4D LiDAR technology uses Frequency Modulated Continuous Wave (FMCW) sensing to simultaneously detect precise distance and velocity.

GLOB faces near-zero growth in 2025 due to macro headwinds and delayed IT spending, but this slowdown is sector-wide, not company-specific. Management is guiding conservatively, yet a strong pipeline and new AI subscription model could drive a 2026 rebound and high-teens growth by 2027. Valuation has reset after the recent selloff; at 0.9x PEG, downside appears limited, and upside could be significant if growth resumes as forecast.

Middleton, Massachusetts, May 19, 2025 (GLOBE NEWSWIRE) -- QKS Group has named PTC as a SPARK leader in its analysis of the SPARK Matrix™: Industrial Internet of Things (IIoT) Platform, 2025 market.

LONDON and NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that its CEO, Gary S. Jacob, Ph.D., will be giving an oral presentation at the 4th Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on May 22, 2025. Dr. Jacob's presentation will cover the development of urcosimod, OKYO's lead clinical drug candidate, to treat neuropathic corneal pain (NCP) which is a debilitating condition affecting many tens …

Investor call and webcast scheduled for today at 8:30 a.m. ET NEW YORK , May 19, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate its Phase 3b clinical trial of NurOwn® (autologous MSC-NTF cells) for the treatment of amyotrophic lateral sclerosis (ALS).

All primary endpoints for safety, tolerability, and clinical response in the intent-to-treat population met AP-SA02 arm significantly improved clinical outcomes and prevented relapse compared to best available antibiotic therapy No treatment-related serious adverse events were observed with repetitive intravenous dosing LOS ANGELES , May 19, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced positive topline results from its Phase 1b/2a diSArm trial which evaluated AP-SA02, a novel intravenous ("IV") administered multi-phage …

Continued momentum in sales to Tier-1 defense manufacturers gearing up for program of record deliveries for end users including the U.S. Department of Defense (DoD) and other major world militaries

Miami, FL, May 19, 2025 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that the Company will attend the B. Riley Securities 25th Annual Institutional Investor Conference in Marina Del Rey, CA on Wednesday, May 21, 2025.